Ann: Receipt of R&D Tax Incentive Payment, page-36

Not sure if you listened to the radio interviews..

Yes it's business as usual at ANP.. and thats what you want...business as usual at ANP...not ASX....


But key notes. ..

1. Dystro combo drug sales were over $800m , now that's some serious number..

Now that makes you think how important that data is... that is coming out in the next 4 weeks..

With MD suggesting what @samfiodiving said...move into clinical trials straight away...


2. Long Covid....MD still saying watch this space....I m guessing some serious discussions must be up...this interview was only a few days ago..as I have have said anything here is welcome....$$ or partnership...

3. Laser focused in starting the trial ..that's what MD said...and yes we need that asap...

4. LGMD won't go unnoticed if Combo trials are a hit...

Time to accumulate these super cheap shares??

This could be 50c by Dec 2023...

Imo DYOR...